The Larvol Group to Participate in the Pharma CI Conference
The Larvol Group, LLC, announced today that it will launch its pharmaceutical CI platform, Larvol DeltaTM at the upcoming Pharma CI Conference on September 11th and 12th in Parsippany, New Jersey.
San Francisco, CA (I-Newswire) September 10, 2012 - The new online platform offers increased functionality to clients including an online weekly news monitor, trial and milestone trackers, a conference tracker, an interactive heatmap and other customized analytics.
Company President, Bruno Larvol will also present at the conference, exploring the role that secondary sources play in advanced monitoring of news, conferences, analyst reports, trials and product milestones for the pharmaceutical industry. Mr. Larvol commented, “Pharma CI has always been an excellent opportunity for The Larvol Group to share recent product developments that enhance our clients’ experience.”
For more information regarding how The Larvol Group might be able to assist your organization, please visit our booth. Alternatively, if you would like to schedule a meeting with Bruno Larvol during the event, please contact Natalie Gulley at email@example.com at 512.426.1966.
The Larvol Group, LLC provides competitive intelligence tracking for the pharmaceutical industry. Our suite of subscription services includes customized brand-level, franchise-level, scientific and strategic monitoring.
The firm includes over 100 professionals worldwide
with a particular focus in oncology, CNS, diabetes
and inflammation as well as expertise in all major therapeutic areas. Our clients include 9 of the top 10 pharmaceutical companies.
About The Larvol Group:
The Larvol Group, LLC, (www.larvol.com) a San Francisco-based competitive intelligence company founded in 2004, provides innovative business intelligence services for the pharmaceutical industry. Their Market Intelligence Reports track relevant news, clinical trials and developments in the competitive landscape of a given indication. Drawing on the knowledge of over 100 professionals, The Larvol Group has expertise in all major therapeutic areas, including oncology, metabolic diseases, CNS, inflammation, cardiovascular, and pain management. Their diverse portfolio of clients includes top pharmaceutical companies and small to midsized biotech firms.
About Larvol Group LLC
Larvol Group LLC
505 Montgomery Street, 11th Floor
Phone : 512-426-1966
Published On:September 10, 2012
Print Release:Print Release
If you have questions regarding information in this press release contact the company listed above. I-Newswire.com is a press release service and not the author of this press release.The information that is on or available through this site is for informational purposes only and speaks only as of the particular date or dates of that information. As some companies and PR Agencies submit their press releases once per week,month or quarter, make sure to check the official company website for accurate release dates as our site displays the I-Newswire.com press release distribution date only.We do not guarantee the accuracy or completeness of information on or available through this site, and we are not responsible for or omissions in that information or for actions taken in reliance on that information.
South Nassau Cancer Program Earns Prestigious Award from ACS Commission on Cancer
Dental Implant Specialists in New York Explain the Three Easy Steps to Getting New Teeth in One Day
MyMedLeads Announces LocateADoc.com Integration, Providing Doctors’ Offices with Enhanced Lead Tracking and Management Capabilities
Premier Bothell Dentist Offers Dental Implants to Develop Beautiful Smiles For Patients
Long Term Care Educational Seminar to Take Place in Dyker Beach, Brooklyn